CalciMedica is trading at $1.78, up 8.54% versus the October 30 regular-session close, with no clear catalyst identified.
- No October 30 company announcement was identified; CalciMedicaβs investor-relations page lists its latest press release as September 8.
- The broader market was sharply lower, moving in the opposite direction. Available evidence does not establish a cause for the after-hours gain.